- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
Patent holdings for IPC class C12N 15/40
Total number of patents in this class: 342
10-year publication summary
16
|
22
|
17
|
24
|
20
|
6
|
17
|
16
|
16
|
11
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Government of The United States of America AS represented by The Secretary of The Department of Health and Human Services | 177 |
6 |
Medicago Inc. | 138 |
6 |
Takeda Vaccines, Inc. | 217 |
6 |
The University of North Carolina at Chapel Hill | 2025 |
6 |
PnuVax Incorporated | 10 |
5 |
Regents of the University of Minnesota | 2682 |
5 |
The Regents of the University of California | 19812 |
4 |
The Trustees of the University of Pennsylvania | 4308 |
4 |
Folia Biotech Inc. | 10 |
4 |
Fundacao Oswaldo Cruz | 105 |
4 |
Icon Genetics GmbH | 47 |
4 |
Kagoshima University | 309 |
4 |
Universite Laval | 713 |
4 |
University of Manitoba | 449 |
4 |
AlphaVax, Inc. | 22 |
3 |
Centers for Disease Control and Prevention | 21 |
3 |
Commonwealth Scientific and Industrial Research Organisation | 1643 |
3 |
Institut Pasteur | 789 |
3 |
International Centre for Genetic Engineering and Biotechnology | 32 |
3 |
The James Hutton Institute | 30 |
3 |
Other owners | 258 |